Human IgA activates the complement system via the Mannan-Binding lectin pathway

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2861-2868

  Roos, A ^a   Bouwman, L H ^a   Van Gijlswijk Janssen, D J ^a   Faber Krol, M C ^a   Stahl, G L ^a   Daha, M R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN A; MANNAN BINDING LECTIN; MANNOSE;

ARTICLE; COMPLEMENT ACTIVATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; MUCOSA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 0035451107     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2861     Document Type: Article

References (44)

1. Mannose binding lectin: The pluripotent molecule of the innate imunity
2. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein
3. A second serine protease associated with mannan-binding lectin that activates complement
4. Mannan-binding lectin associated serine protease 3 (MASP-3): A new component of the lectin pathway of complement activation
5. Proteolytic activities of two types of mannose-binding lectin-associated serine protease
6. Genetics of human mannan-binding protein
7. Distinct and overlapping functions of allelic forms of human mannose binding protein
8. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series
9. Mannose binding protein gene mutations associated with unusual and severe infections in adults
10. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis
11. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus
12. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis
13. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition
14. Biological activity of IgA
15. Mucosal immunoglobulins
16. Activation of the alternative pathway of complement by human serum IgA
17. Immunoglobulin A: Interaction with complement, phagocytic cells and endothelial cells
18. IgA nephropathy and related diseases
19. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy
20. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy
21. 2+-independent association with a C1s-like serine protease
22. Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity
23. Complement activation after oxidative stress: Role of the lectin complement pathway
24. Distinct pathways of mannan-binding lectin (MBL)- and Cl-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2
25. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway
26. Activation of rat complement by soluble and insoluble rat IgA immune complexes
27. Activation of complement by human serum IgA, secretory IgA and IgA1 fragments
28. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies
29. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes
30. Complement depletion abolishes IgA-mediated glomerular inflammation in rats
31. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy
32. Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis
33. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89
34. Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells
35. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA
36. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers
37. Macromolecular IgA in the circulation and mesangial deposits in patients with primary IgA nephropathy
38. Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses
39. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
40. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein
41. Interaction of C1.q and the collectins with the potential receptors calreticulin (cC1qR/collectin receptor) and megalin
42. r component of the C1q receptor
43. Mechanisms of phagocytosis in macrophages
44. Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis